Back to search
FDAFDA · Food and drugs·Recall number D-1073-2019

8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02

Published April 10, 2019 · Recall initiated: March 15, 2019

Summary

FDA records drug Class I recall D-1073-2019, published April 10, 2019 and initiated March 15, 2019. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 283,400 vials; Lot: Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; glass particulates

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
United States and Puerto Rico
Lot
Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02 recalled?

Yes. FDA published recall D-1073-2019 on April 10, 2019. Reported hazard: Presence of Particulate Matter; glass particulates

What should I do if I have this product?

Voluntary: Firm initiated · Press Release